TY  - CHAP
AB  - Research sponsored by entities in developed countries, but conducted in developing countries, has recently been the focus of academic debate, international declarations and media controversy. Much of this attention has focused on whether the trials are exploitative and if so what should be done to avoid exploitation. This chapter takes Alan Wertheimer's principles of mutually advantageous transactions and applies them to the question of exploitation in international research. In this chapter, I develop an analysis of exploitation and apply this to the hypothesis that some pharmaceutical companies who run drug trials in developing countries wrongfully exploit the trial participants.
VL  - 9
SN  - 978-1-84950-412-6, 978-0-76231-311-2/1479-3709
DO  - 10.1016/S1479-3709(06)09010-8
UR  - https://doi.org/10.1016/S1479-3709(06)09010-8
AU  - Ballantyne Angela
ED  - John Balint
ED  - Sean Philpott
ED  - Robert Baker
ED  - Martin Strosberg
PY  - 2006
Y1  - 2006/01/01
TI  - Chapter 10: Under What Conditions is Clinical Research in Developing Countries Exploitative? A Framework for Assessing Exploitation in Mutually Advantageous Transactions
T2  - Ethics and Epidemics
T3  - Advances in Bioethics
PB  - Emerald Group Publishing Limited
SP  - 209
EP  - 244
Y2  - 2024/05/12
ER  -